Literature DB >> 7226865

Cerebral perfusion pressure and abnormal intracranial pressure wave forms: their relation to outcome in birth asphyxia.

T N Raju, D Vidyasagar, C Papazafiratou.   

Abstract

Intracranial pressure (ICP) studies were carried out in 14 infants with severe birth asphyxia and brain damage. A markedly low cerebral perfusion pressure (CPP) was noted in infants who died and in 1 infant who survived with cerebral palsy. The long-term ICP tracing revealed negative waves and plateau waves in 2 infants. Cushing response was noted in 2 infants who had elevated ICP. The value and significance of evaluated CPP and of abnormal waveforms are discussed.

Entities:  

Mesh:

Year:  1981        PMID: 7226865     DOI: 10.1097/00003246-198106000-00003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

1.  Cerebral blood flow velocity pattern in healthy and asphyxiated newborns: a controlled study.

Authors:  F van Bel; M van de Bor; T Stijnen; J Baan; J H Ruys
Journal:  Eur J Pediatr       Date:  1987-09       Impact factor: 3.183

2.  Cyclical variation of blood pressure and heart rate in neonates.

Authors:  S Cunningham; S Deere; N McIntosh
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

3.  Intracranial pressure monitoring.

Authors:  R A Minns
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

Review 4.  "Half a Century of Evolution of Neonatology: A Witness's Story" : Dr. K. C. Chaudhuri Lifetime Achievement Award Oration Delivered at AIIMS, New Delhi on 7th September 2014.

Authors:  Dharmapuri Vidyasagar
Journal:  Indian J Pediatr       Date:  2015-08-05       Impact factor: 1.967

5.  Hypertensive response to raised intracranial pressure in infancy.

Authors:  A M Kaiser; A G Whitelaw
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

6.  Medical management of raised intracranial pressure after severe birth asphyxia.

Authors:  M I Levene; D H Evans
Journal:  Arch Dis Child       Date:  1985-01       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.